Trial intelligence / Profile preview

Northera in Dysautonomia for Menkes Disease and Occipital Horn Syndrome

NCT04977388Phase 2Completed

Start
Jul 2021
Primary completion
Oct 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of droxidopa in dysautonomia. Started Jul 2021; status: completed.

02

Drugs

droxidopa
03

Conditions

dysautonomia

Beyond the preview

Go deeper on NCT04977388.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04977388.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call